| Selective IKK2 inhibitor IMD0354 disrupts NF-κB signaling to suppress corneal inflammation and angiogenesis A Lennikov, P Mirabelli, A Mukwaya, M Schaupper, M Thangavelu, ... Angiogenesis 21 (2), 267-285, 2018 | 71 | 2018 |
| The tumor microenvironment—a metabolic obstacle to NK cells’ activity J Domagala, M Lachota, M Klopotowska, A Graczyk-Jarzynka, ... Cancers 12 (12), 3542, 2020 | 41 | 2020 |
| PRDX-1 supports the survival and antitumor activity of primary and CAR-modified NK cells under oxidative stress M Klopotowska, M Bajor, A Graczyk-Jarzynka, A Kraft, Z Pilch, A Zhylko, ... Cancer immunology research 10 (2), 228-244, 2022 | 34 | 2022 |
| Time-dependent LXR/RXR pathway modulation characterizes capillary remodeling in inflammatory corneal neovascularization A Mukwaya, A Lennikov, M Xeroudaki, P Mirabelli, M Lachota, L Jensen, ... Angiogenesis 21 (2), 395-413, 2018 | 33 | 2018 |
| NF-κB activation in retinal microglia is involved in the inflammatory and neovascularization signaling in laser-induced choroidal neovascularization in mice F Hikage, A Lennikov, A Mukwaya, M Lachota, Y Ida, TP Utheim, DF Chen, ... Experimental cell research 403 (1), 112581, 2021 | 17 | 2021 |
| Prospects for NK cell therapy of sarcoma M Lachota, M Vincenti, M Winiarska, K Boye, R Zagożdżon, KJ Malmberg Cancers 12 (12), 3719, 2020 | 14 | 2020 |
| Bioinformatic analysis reveals central role for tumor-infiltrating immune cells in uveal melanoma progression M Lachota, A Lennikov, KJ Malmberg, R Zagozdzon Journal of Immunology Research 2021, 1-18, 2021 | 9 | 2021 |
| Exclusion of older adults from clinical trials in cancer-related pain K Krysa, E Kowalczyk, J Borysowski, M Lachota, T Pasierski Frontiers in Medicine 9, 945481, 2022 | 5 | 2022 |
| Mapping the chemotactic landscape in NK cells reveals subset-specific synergistic migratory responses to dual chemokine receptor ligation M Lachota, K Zielniok, D Palacios, M Kanaya, L Peena, HJ Hoel, ... EBioMedicine 96, 2023 | 4 | 2023 |
| Chimeric Antigen Receptor T Cell Therapy for Pancreatic Cancer: A Review of Current Evidence A Czaplicka, M Lachota, L Pączek, R Zagożdżon, B Kaleta Cells 13 (1), 101, 2024 | 3 | 2024 |
| Regulatory T cells contribute to the immunosuppressive phenotype of neutrophils in a mouse model of chronic lymphocytic leukemia A Goral, M Sledz, A Manda-Handzlik, A Cieloch, A Wojciechowska, ... Experimental Hematology & Oncology 12 (1), 89, 2023 | 3 | 2023 |
| Osteopontin gene polymorphisms rs1126616 C> T and rs1126772 A> G are associated with atopic dermatitis in polish population B Kaleta, M Lachota, J Łukaszkiewicz, A Woźniacka, J Bogaczewicz The Application of Clinical Genetics, 417-425, 2021 | 2 | 2021 |
| Optimizing the therapeutic potential of tyrosine kinase inhibitors in chemo-immunotherapy of B-cell acute lymphoblastic leukemia involving rituximab K Domka, M Poprzeczko, Z Urbanska, L Komorowski, A Pastorczak, ... Cancer Research 82 (12_Supplement), 3324-3324, 2022 | 1 | 2022 |
| Dasatinib effect on NK cells and anti-tumor immunity M Lachota, M Siernicka, Z Pilch, A Graczyk-Jarzynka, M Winiarska Blood 132, 3004, 2018 | 1 | 2018 |
| Analysis of chemokine network in primary human glioblastoma M Lachota, K Zielniok, A Gozdz, P Szpak, I Kalaszczynska, R Zagozdzon The Journal of Immunology 208 (1_Supplement), 179.06-179.06, 2022 | | 2022 |
| Innate-like Chemokine Receptor Profile and Migratory Behaviour By Terminally Differentiated and Educated NK Cells M Lachota, DA Palacios, D Clement, EH Ask, HJ Hoel, MT Wiiger, ... Blood 136, 24-25, 2020 | | 2020 |
| Comprehensive flow cytometry analysis of chemokine receptors expressed on human natural killer cells M Lachota | | |
Radoslaw ZagozdzonVerified email at wum.edu.pl
